Stereotaxis STXS
NYSE STXS
$1.42 -0.02 (-1.39%)
At close: Aug 21, 2026 · 4:00 PM EDT

Stereotaxis (STXS) Cash & Current Investments (2010 - 2026)

Stereotaxis (STXS) posted quarterly Cash & Current Investments of $14.6 million for Q1 2026, up 36.74% year-over-year from $10.7 million in Q1 2025, and up 8.9% quarter-over-quarter from $13.4 million in Q4 2025.

Stereotaxis (STXS) Cash & Current Investments (2010 - 2026) Analysis & Trends

Stereotaxis (STXS) has reported Cash & Current Investments for 17 consecutive years, with $14.6 million the latest figure, recorded in Q1 2026.

  • In Q1 2026, Cash & Current Investments rose 36.74% year-over-year to $14.6 million; the TTM figure through Mar 2026 stood at $14.6 million (up 36.74% YoY), while the FY2025 annual figure was $13.4 million, up 7.92% from the prior year.
  • Cash & Current Investments grew to $14.6 million in Q1 2026 per STXS's latest filing, from $13.4 million in the prior quarter.
  • Across five years, Cash & Current Investments topped out at $49.5 million in Q4 2022 and bottomed at $7.0 million in Q2 2025.
  • Historically, Cash & Current Investments has averaged $20.3 million across 5 years, with a median of $15.6 million in 2024.
  • Annual changes were most pronounced in 2023 — Cash & Current Investments slumped 80.56% — and 2024, when it surged 157.67%.
  • Stereotaxis' Cash & Current Investments stood at $49.5 million in 2022, then tumbled by 57.44% to $21.1 million in 2023, then tumbled by 41.03% to $12.4 million in 2024, then climbed by 7.92% to $13.4 million in 2025, then rose by 8.9% to $14.6 million in 2026.
  • Business Quant data shows STXS's Cash & Current Investments at $14.6 million in Q1 2026, $13.4 million in Q4 2025, and $10.5 million in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Intuitive Surgical 134.13 Bn 128.91 Bn 1.96 Bn 5.22 Bn
2 Becton Dickinson 52.76 Bn 51.90 Bn 2.32 Bn 863.00 Mn
3 Alcon 35.81 Bn 34.46 Bn 1.68 Bn 1.36 Bn
4 Resmed 33.72 Bn 32.25 Bn 861.22 Mn 1.47 Bn
5 Medline 29.38 Bn 26.70 Bn 2.22 Bn 2.68 Bn
6 West Pharmaceutical Services 25.00 Bn 24.57 Bn 329.20 Mn 435.80 Mn
7 Solventum 15.46 Bn 15.06 Bn 1.29 Bn 403.00 Mn
8 Cooper Companies 14.88 Bn 14.74 Bn 735.40 Mn 138.80 Mn
9 Baxter International 13.58 Bn 11.43 Bn 1.03 Bn 2.15 Bn
10 Stereotaxis 141.91 Mn 127.29 Mn 3.79 Mn 14.62 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 14.62 Mn
Dec 31, 2025 13.42 Mn
Sep 30, 2025 10.51 Mn
Jun 30, 2025 6.97 Mn
Mar 31, 2025 10.69 Mn
Dec 31, 2024 12.44 Mn
Sep 30, 2024 11.01 Mn
Jun 30, 2024 15.65 Mn
Mar 31, 2024 18.77 Mn
Dec 31, 2023 21.09 Mn
Sep 30, 2023 22.63 Mn
Jun 30, 2023 24.50 Mn
Mar 31, 2023 7.29 Mn
Dec 31, 2022 49.54 Mn
Sep 30, 2022 33.05 Mn
Jun 30, 2022 35.74 Mn
Mar 31, 2022 37.47 Mn
Dec 31, 2021 40.60 Mn
Sep 30, 2021 41.85 Mn
Jun 30, 2021 43.54 Mn